SI2032126T1 - Formulacija z rabeprazolom - Google Patents

Formulacija z rabeprazolom

Info

Publication number
SI2032126T1
SI2032126T1 SI200730761T SI200730761T SI2032126T1 SI 2032126 T1 SI2032126 T1 SI 2032126T1 SI 200730761 T SI200730761 T SI 200730761T SI 200730761 T SI200730761 T SI 200730761T SI 2032126 T1 SI2032126 T1 SI 2032126T1
Authority
SI
Slovenia
Prior art keywords
rabeprazole
formulation
pharmaceutically acceptable
pharmaceutical composition
tablet
Prior art date
Application number
SI200730761T
Other languages
English (en)
Inventor
Rok Jurecic
Miha Tomaz Jaklic
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI2032126T1 publication Critical patent/SI2032126T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200730761T 2006-06-29 2007-06-27 Formulacija z rabeprazolom SI2032126T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06013440A EP1872778A1 (en) 2006-06-29 2006-06-29 Stable pharmaceutical composition with rabeprazole sodium
PCT/EP2007/005691 WO2008000463A2 (en) 2006-06-29 2007-06-27 Rabeprazole formulation
EP07764889A EP2032126B1 (en) 2006-06-29 2007-06-27 Rabeprazole formulation

Publications (1)

Publication Number Publication Date
SI2032126T1 true SI2032126T1 (sl) 2011-12-30

Family

ID=37398281

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730761T SI2032126T1 (sl) 2006-06-29 2007-06-27 Formulacija z rabeprazolom

Country Status (6)

Country Link
EP (2) EP1872778A1 (sl)
AT (1) ATE517612T1 (sl)
AU (1) AU2007263981B2 (sl)
ES (1) ES2370664T3 (sl)
SI (1) SI2032126T1 (sl)
WO (1) WO2008000463A2 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011009223A1 (de) 2011-01-13 2012-07-19 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Multifunktionelles Kompositmaterial zur Luft- und Abwasserreinigung
CN103202818A (zh) * 2012-01-15 2013-07-17 山东新时代药业有限公司 一种含有右旋雷贝拉唑或其可药用盐的肠溶片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
KR100627614B1 (ko) * 1998-04-20 2006-09-25 에자이 가부시키가이샤 안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
CA2517289A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Stable pharmaceutical composition of rabeprazole and processes for their preparation
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
EP1696889A1 (en) * 2003-08-28 2006-09-06 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of benzimidazole and processes for their preparation
NZ549838A (en) * 2004-03-26 2010-04-30 Eisai R&D Man Co Ltd Coated controlled-release preparation containing a gastric acid secretion inhibitor
US20090148519A1 (en) * 2005-09-29 2009-06-11 Yasuhiro Zaima Pulsed-release preparation having improved disintegration properties in vivo

Also Published As

Publication number Publication date
AU2007263981A1 (en) 2008-01-03
EP1872778A1 (en) 2008-01-02
WO2008000463A2 (en) 2008-01-03
ES2370664T3 (es) 2011-12-21
EP2032126A2 (en) 2009-03-11
AU2007263981B2 (en) 2012-08-09
EP2032126B1 (en) 2011-07-27
WO2008000463A3 (en) 2008-03-06
ATE517612T1 (de) 2011-08-15

Similar Documents

Publication Publication Date Title
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2007087431A3 (en) Sublingual fentanyl spray
ZA200903929B (en) Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
WO2009017837A3 (en) Sublingual fentanyl spray
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
SI2086945T1 (sl) Novi postopek za pripravo statinov in njihovih farmacevtsko sprejemljivih soli
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
TN2010000011A1 (en) Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
RS54244B1 (en) NALBUFINE BASED FORMULATIONS AND THEIR USE
WO2009140341A3 (en) Atorvastatin compositions
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2005079759A3 (en) Pharmaceutical composition for oral application and method for preparing thereof
WO2010001413A3 (en) Sustained release pharmaceutical compositions comprising quetiapine
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
WO2008034912A3 (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
SI2032126T1 (sl) Formulacija z rabeprazolom
WO2009060064A3 (en) Pharmaceutical formulations for the oral administration of ppi
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
WO2013098268A3 (en) Tablets and dry-coated agents
WO2009087657A3 (en) Stable pharmaceutical composition of duloxetine and process for its preparation
EP2101742B8 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
WO2009150238A3 (en) Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2010013925A3 (en) Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof